The invention relates to a composition and/or method for reducing and/or preventing myopia progression. The composition comprises an ultra-low atropine concentration. The composition comprises less than 0.025% atropine. For example, the composition comprises about 0.01% atropine. The ultra-low atropine composition reduces and/or prevents myopia progression with negligible side effects, such as loss of accommodation, mydriasis, near-vision blur, allergic conjunctivitis and dermatitis.
展开▼
